Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

SKU ID : DPI- 12785797

Publishing Date : 11-Dec-2018

No. of pages : 180


  • The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025.

    ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for global blockbuster drugs market. The report includes historic data from 2015 to 2017 and forecasts until 2025.

    The report contains a granular analysis of the present industry situations, market demands, reveals facts on the market size, revenues and provides forecasts through 2025. The report provides clear insight into current and future developments of the global blockbuster drugs market. The report explores detailed analysis of top 50 drugs market assessment globally from 2015 to 2017 and forecasts to 2025. The report also details the latest information about the global research & development spend by pharma & biotech companies

    Additionally, the report includes assessment of most valuable drugs research and development projects insights by phase and market value. Key trends in terms of collaboration, merger & acquisition, partnerships and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the global blockbuster drugs market.

    The report concludes with the profiles of major players in the global blockbuster drugs market. The key market players are evaluated on various parameters such as business overview and recent development.

    The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:

    1) AbbVie
    2) Celgene
    3) Gilead Science
    4) Merck
    5) Roche
    6) Bristol–Myers Squibb
    7) Pfizer
    8) Johnson & Johnson
    9) Amgen
    10) Biogen
    11) Bayer
    12) Regeneron Pharmaceuticals
    13) Novo Nordisk
    14) Allergan
    15) Alexion Pharmaceuticals
    16) GlaxoSmithKline
    17) Novartis
    18) Eli Lilly and Company
    19) Astrazeneca
    20) Incyte Corporation
    21) Boehringer Ingelheim
    22) Astellas Pharma

    Top 50 Blockbuster Drugs Covered Under This Report Are:

    1) Humira
    2) Imbruvica
    3) Revlimid
    4) Genvoya
    5) Truvada
    6) Harvoni
    7) Epclusa
    8) Keytruda
    9) Januvia/Janumet
    10) Herceptin
    11) Avastin
    12) MabThera/Rituxan
    13) Perjeta
    14) Opdivo
    15) Eliquis
    16) Orencia
    17) Sprycel
    18) Lyrica
    19) Ibrance
    20) Simponi
    21) Stelara
    22) Zytiga
    23) Invega Sustenna
    24) Xarelto
    25) Enbrel
    26) Tagrisso
    27) Tecfidera
    28) Eylea
    29) Victoza
    30) Botox
    31) Soliris
    32) Triumeq
    33) Seretide/Advair
    34) Gilenya
    35) Cosentyx
    36) Trulicity
    37) Cialis
    38) Humalog
    39) Symbicort
    40) Zepatier
    41) Pomalyst/Imnovid
    42) Darzalex
    43) Prolia/Xgeva
    44) Ocrevus
    45) Xtandi
    46) Tivicay
    47) Jakafi/Jakavi
    48) Jardiance
    49) Trajenta / Jentadueto
    50) Relvar/Breo Ellipta

    The Latest Industry Data Included in this Report:

    Global Top 50 Blockbuster Drugs Market Size & Analysis (2015 – 2025)
    Global Top 50 Blockbuster Drugs Market Share & Y–o–Y Growth (%), 2015 – 2025
    Global Top 50 Blockbuster Drugs Market Assessment & Opportunity, (2015 – 2025)
    Most Valuable Drugs Research and Development (R&D) Projects Insights by Phase and Market Value
    Global Research & Development (R&D) Spend by Pharma & Biotech Companies (2015 – 2025)
    Major Deals (Mergers, Acquisitions, Key Agreements, Partnerships & Collaborations)
    Key Market Drivers and Inhibitors of the Global Blockbuster Drugs Market
    Major Companies Analysis

    The Answers to the Following Key Questions can be found in the Report:

    What is the size of the global top 50 blockbuster drugs market during 2015 -2025?
    What will be the revenue generated by each drug during the forecast period?
    Which major drugs provides highest market share?
    How are the overall market and major drugs growing?
    What are the key drivers and inhibitors in the current market?
    What will be the impact of drivers and inhibitors in the future?
    How is the market predicted to develop in the future?
    Who are the key players in this market space?